Dataset grows to more than 312,000 whole genomes with longitudinal clinical data. GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data.

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.

The findings could suggest ways to intervene before clinical symptoms of memory and cognitive impairment become apparent.

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group.

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.